Menu Search
Equities

Opsy Holding AB

  • Add to watchlist
  • Add to portfolio
  • Add an alert
K6Q:FRA

Opsy Holding AB

Actions
  • Price (EUR)0.486
  • Today's Change-0.002 / -0.41%
  • Shares traded--
  • 1 Year change--
  • Beta-0.0842
Data delayed at least 15 minutes, as of Feb 06 2026 14:25 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Opsy Holding AB, formerly WntResearch AB, is a Sweden-based company engaged in the translational cancer research. Its aim is to develop anti-metastatic therapies based on an increased understanding of the mechanisms underlying the metastatic process and the evaluation of specific small molecules that can specifically interact with this process. The Company’s programs focus on the role of the Wnt-5a protein in the metastatic process.

  • Revenue in SEK (TTM)4.13m
  • Net income in SEK-18.69m
  • Incorporated2007
  • Employees7.00
  • Location
    Opsy Holding ABPer Albin Hanssons Vag 41 BvMALMO 214 32SwedenSWE
  • Phone+46 8202011
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.